CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

Published: September 2014
No. of Pages: 263
   

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Australia". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The population of Australia in 2013 was 23.2 million, having grown at a CAGR of 1.6% from 2008. Medicare is Australia's public health insurance scheme, and provides free or subsidized healthcare services to the Australian population. The government is attempting to reduce the barriers to manufacturing drugs and encourage exports through the introduction of various new policies.

In 2013, the government spent $1 billion on R&D on medical and health science and exported $3.8 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $18 billion in 2008 and is projected to reach $32 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 5.1%. The medical device market was valued at $5.9 billion in 2008 and is projected to grow at a CAGR of 4.9% to $10.4 billion by 2020. These positive growth trends can be primarily attributed to -

  • An increasingly elderly population
  • Universal health coverage
  • Government initiatives

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Australia, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, AstraZeneca, Novartis, Sanofi and Alphapharm; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Medtronic, DePuy companies and F.Hoffmann-La Roche
  • An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country's political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Australian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Australia's healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Australia's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
  • Identify, understand, and capitalize on the opportunities and challenges in Australia's healthcare market

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

Table of Contents

1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 14

2 Introduction 19
2.1 GlobalData Report Guidance 19

3 Overview of Pharmaceutical and Medical Device Markets 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Pharmaceutical Exports and Imports 23
3.1.3 Supply Channels 24
3.1.4 Market Segments 26
3.1.5 Overview of Top Five Disease Areas 29
3.1.6 Major Players 31
3.1.7 Pfizer 33
3.1.8 AstraZeneca 41
3.1.9 Novartis 50
3.1.10 Sanofi 61
3.1.11 Alphapharm 67
3.2 Medical Device Market 69
3.2.1 Market Overview 69
3.2.2 Overview of the Top Five Segments 72
3.2.3 Diagnostic Market 87
3.2.4 Major Players 89
3.2.5 Siemens Healthcare 90
3.2.6 GE Healthcare 95
3.2.7 Medtronic 104
3.2.8 DePuy Companies 112
3.2.9 F. Hoffmann-La Roche 118
3.3 Market Drivers and Barriers 125
3.3.1 Drivers 125
3.3.2 Barriers 126

4 Market Access 128
4.1 Reimbursement and Payer Landscape 128
4.1.1 Overview of Healthcare System 128
4.1.2 Reimbursement Process 128
4.1.3 Overview of Insurance Providers 132
4.1.4 Patient Share in Healthcare Spending 139
4.1.5 Price Trend in Healthcare Services 140
4.1.6 Pricing Policies 141
4.2 Regulatory Landscape 143
4.2.1 Overview of Regulatory Agencies 143
4.2.2 Market Authorization Procedure for Pharmaceutical Products 144
4.2.3 New Medical Device Approval Process 149
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 155
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 156
4.2.6 Intellectual Property Rights 157
4.2.7 Clinical Trial Regulations 160
4.2.8 Pharmaceutical Advertising Regulations 162
4.2.9 Pharmacy Regulations 164
4.2.10 Labeling and Packaging Regulations 165

5 Country Analysis 167
5.1 Political Environment 167
5.1.1 Political Structure 167
5.1.2 Analysis of Current Political Environment 168
5.1.3 Healthcare Policy Initiatives 169
5.2 Economic Landscape 171
5.3 Economic Indicators 173
5.3.1 Gross Domestic Product 173
5.3.2 Gross National Income 178
5.3.3 Inflation 179
5.3.4 Currency Exchange Rate 182
5.3.5 Foreign Direct Investment 183
5.3.6 Foreign Exchange Reserves 185
5.3.7 Trade Balance 186
5.3.8 Government Structural Balance 188
5.3.9 Government Net Debt 190
5.3.10 Major Industries 191
5.4 Demographics 192
5.4.1 Population 192
5.4.2 Education and Literacy 211
5.4.3 Employment 215
5.4.4 Disease Burden 216
5.5 Healthcare Infrastructure 220
5.5.1 Healthcare Facilities 220
5.5.2 Healthcare Parameters 227
5.5.3 Environmental Health 231
5.5.4 Healthcare Personnel 235
5.6 Healthcare Expenditure 238
5.6.1 Overview 238
5.6.2 Major Components of Healthcare Spending 240
5.6.3 Public and Private Sector Share 241
5.6.4 Spending in Pharmaceutical Research and Development 242
5.7 Trade Associations 243
5.7.1 Australian Pharmaceutical Marketing and Research Group 243
5.7.2 Pharmacy Guild of Australia 243
5.7.3 Generic Medicines Industry Association 243
5.8 Trade Fairs 244

6 Opportunities and Challenges 245
6.1 Opportunities 245
6.2 Challenges 245

7 Appendix 247
7.1 Abbreviations 247
7.2 Bibliography 250
7.3 Research Methodology 260
7.3.1 Coverage 260
7.3.2 Secondary Research 261
7.3.3 Forecasts 261
7.3.4 Expert Panel 261
7.4 Disclaimer 262

List of Tables

Table 1: Pharmaceutical Market, Australia, Revenue* ($bn), 2008-2013 21
Table 2: Pharmaceutical Market, Australia, Revenue* Forecast ($bn), 2014-2020 22
Table 3: Pharmaceutical Market, Australia, Exports and Imports ($bn), 2008-2013 23
Table 4: Pharmaceutical Market, Australia, Pharmacy and Wholesale Mark-up (%), 2014 25
Table 5: Pharmaceutical Market, Australia, Biotechnology Companies, Market Capitalization ($m), Q4 2013 27
Table 6: Pharmaceutical Market, Australia, Over-the-Counter Drugs Market ($bn), 2008-2013 28
Table 7: Pharmaceutical Market, Australia, Top Five Therapeutic Areas, Pharmaceutical Expenditure ($bn), 2013 30
Table 8: Pharmaceutical Market, Australia, Major Suppliers to PBS, Revenue ($m), 2013 32
Table 9: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 34
Table 10: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014* 35
Table 11: Pharmaceutical Market, AstraZeneca, Global, Major Products by Therapy Area, Revenue ($bn) and Annual Growth (%), 2013 43
Table 12: Pharmaceutical Market, AstraZeneca, Global, Late-stage Pipeline, 2014 44
Table 13: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 51
Table 14: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2018* 52
Table 15: Pharmaceutical Market, Sanofi, Global, Major Products, Revenue ($bn), 2013 62
Table 16: Pharmaceutical Market, Sanofi, Global, Late-Stage Pipeline, 2014* 63
Table 17: Pharmaceutical Market, Alphapharm, Global, Major Products,2013 67
Table 18: Medical Device Market, Australia, Revenue ($bn), 2008-2013 71
Table 19: Medical Device Market, Australia, Revenue Forecast ($bn), 2014-2020 72
Table 20: Medical Device Market, Australia, Revenue by Segment, 2013 73
Table 21: Medical Device Market, Australia, IVD Devices Market, Revenue ($m), 2008-2013 75
Table 22: Medical Device Market, Australia, IVD Devices Market, Sales Trends for Major Players, 2012 76
Table 23: Medical Device Market, Australia, Orthopedics Devices Market ($m), 2008-2013 77
Table 24: Medical Device Market, Australia, Orthopedics Devices Market, Sales Trends for Major Players, 2008-2012 78
Table 25: Medical Device Market, Australia, Ophthalmic Devices Market, Revenue ($m), 2008-2013 80
Table 26: Medical Device Market, Australia, Ophthalmic Devices Market, Sales Trends for Major Players, 2012 81
Table 27: Medical Device Market, Australia, Cardiovascular Devices Market, Revenue ($m), 2008-2013 82
Table 28: Medical Device Market, Australia, Cardiovascular Devices Market, Sales Trends for Major Players, 2008-2012 83
Table 29: Medical Device Market, Australia, Diagnostic Imaging Market, Sales Trends for Major Players, 2012 86
Table 30: Medical Device Market, Australia, Diagnostic Market, Revenue ($bn), 2008-2013 88
Table 31: Medical Device Market, Australia, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 88
Table 32: Medical Device Market, Australia, Major Medical Device Companies' Revenue, 2012 89
Table 33: Medical Device Market, Medtronic, Global, Major Products, Revenue ($bn), 2013 105
Table 34: Medical Device Market, F. Hoffmann-La Roche, Global, Major Products, 2014 119
Table 35: Market Access, Australia, Private Health Insurance Rate (%), 2014 137
Table 36: Market Access, Australia, Private Insurance Coverage (million), 2008-2013 138
Table 37: Healthcare Spending, Australia, Out-of-Pocket Expenditure (%), 2008-2013 139
Table 38: Market Access, Australia, Average Price of Healthcare Services (%), 2008-2013 140
Table 39: Market Access, Australia, Classification of Medical Devices,, 2013 149
Table 40: Market Access, Australia, Trademark Fees by E-services, 2014 159
Table 41: Market Access, Australia, Trademark Fees by Other Means, 2014 160
Table 42: Market Access, Australia, Regulation of Advertising of Therapeutic Goods, Australia, 2013 163
Table 43: Economic Indicators, Australia, Gross Domestic Product per Capita ($), 2008-2013 175
Table 44: Economic Indicators, Australia, Gross Domestic Product per Capita ($), Forecast, 2014-2020 175
Table 45: Economic Indicators, Australia, Gross Domestic Product Annual Growth (%), 2008-2013 176
Table 46: Economic Indicators, Australia, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 177
Table 47: Economic Indicators, Australia, Gross National Income per Capita ($), 2008-2013 178
Table 48: Economic Indicators, Australia, Average Consumer Price Index, 2008-2013 180
Table 49: Economic Indicators, Australia, Average Consumer Price Index Forecast, 2014-2020 181
Table 50: Economic Indicators, Australia, Average Consumer Price, Annual Change (%), 2008-2013 182
Table 51: Economic Indicators, Australia, Currency Exchange Rate (AUD/$), 2008-2013 183
Table 52: Economic Indicators, Australia, Foreign Direct Investment ($bn), 2008-2013 184
Table 53: Economic Indicators, Australia, Foreign Exchange Reserves ($bn), 2008-2013 185
Table 54: Economic Indicators, Australia, Imports of Goods and Services ($bn), 2008-2013 187
Table 55: Economic Indicators, Australia, Exports of Goods and Services ($bn), 2008-2013 188
Table 56: Economic Indicators, Australia, General Government Structural Balance ($bn),2008-2013 189
Table 57: Economic Indicators, Australia, General Government Net Debt ($bn), 2008-2013 190
Table 58: Economic Indicators, Australia, Major Industries, Gross Value Added (%), 2012-2013 192
Table 59: Demographics, Australia, Population (million), 2008-2013 193
Table 60: Demographics, Australia, Population Forecast (million), 2014-2020 194
Table 61: Demographics, Australia, Population, Urban and Rural Population Share (%), 2008-2013 196
Table 62: Demographics, Australia, Population, Urban and Rural Population Share Forecast (%), 2014-2020 197
Table 63: Demographics, Australia, Population Distribution by Age Group (%), 2008-2013 198
Table 64: Demographics, Australia, Population Distribution by Age Group Forecast (%), 2014-2020 199
Table 65: Demographics, Australia, Births (per 1,000 Population), 2008-2013 200
Table 66: Demographics, Australia, Mortality (per 1,000 Population), 2008-2013 201
Table 67: Demographics, Australia, Major Causes of Mortality, 2012 203
Table 68: Demographics, Australia, Children ?5 Years, Mortality Rate (per 1,000 Live Births), 2008-2013 204
Table 69: Demographics, Australia, Immunization Rate (%), 2008-2013 205
Table 70: Demographics, Australia, Major Causes of Male Mortality (‘000), 2012 207
Table 71: Demographics, Australia, Major Causes of Female Mortality (‘000), 2012 208
Table 72: Demographics, Australia, Gender Ratio (M/F), 2008-2013 209
Table 73: Demographics, Australia, Life Expectancy at Birth (Years), 2008-2013 211
Table 74: Demographics, Australia, Student Enrollment by Level of Education (% of Gross), 2008-2013 213
Table 75: Demographics, Australia, Overseas Students (%), 2008-2013 215
Table 76: Demographics, Australia, Unemployment Rate (%), 2008-2013 216
Table 77: Demographics, Australia, Major Causes of Hospitalization, 2012-2013 218
Table 78: Demographics, Australia, Major Diseases, DALYs (per 100,000 Population), 2004 219
Table 79: Healthcare Infrastructure, Australia, Hospitals, 2008-2013 220
Table 80: Healthcare Infrastructure, Australia, Public and Private Hospitals, 2008-2013 222
Table 81: Healthcare Infrastructure, Australia, Public Acute Care Hospitals, 2008-2013 223
Table 82: Healthcare Infrastructure, Australia, Public Psychiatric Hospitals, 2008-2013 224
Table 83: Healthcare Infrastructure, Australia, Private Free-standing Day Hospitals, 2008-2013 225
Table 84: Healthcare Infrastructure, Australia, Other Private Hospitals, 2008-2013 225
Table 85: Healthcare Infrastructure, Australia, Diagnostic Equipment (per Million Population), 2008-2013 226
Table 86: Healthcare Infrastructure, Australia, Total Hospital Beds (per 1,000 Population), 2008-2013 228
Table 87: Healthcare Infrastructure, Australia, Public Hospital Beds (per 1,000 Population), 2008-2013 228
Table 88: Healthcare Infrastructure, Australia, Private Hospital Beds (per 1,000 Population), 2008-2013 229
Table 89: Healthcare Infrastructure, Australia, Doctors (per 100,000 Population), 2008-2013 230
Table 90: Healthcare Infrastructure, Australia, PM10 (µg/m3), 2008-2013 232
Table 91: Healthcare Infrastructure, Australia, CO2 Emissions (Million Metric Tons), 2008-2013 234
Table 92: Healthcare Infrastructure, Australia, Nurses (per 1,000 Population), 2008-2013 235
Table 93: Healthcare Infrastructure, Australia, Pharmacists (per 1,000 Population), 2008-2013 236
Table 94: Healthcare Infrastructure, Australia, Dentists (per 1,000 Population), 2008-2013 237
Table 95: Healthcare Expenditure, Australia, Healthcare Expenditure (% of GDP), 2008-2013 239
Table 96: Healthcare Expenditure, Australia, Healthcare Expenditure, Share of Major Components (%), 2012 240
Table 97: Healthcare Expenditure, Australia, Healthcare Expenditure, Public-Private Share (%), 2008-2013 241
Table 98: Healthcare Expenditure, Australia, Research and Development Expenditure in Medical and Health Sciences ($m), 2008-2013 242
Table 99: Healthcare Expenditure, Australia, Major Healthcare Trade Fairs, 2014-2015 244

List of Figures

Figure 1: Pharmaceutical Market, Australia, Revenue* ($bn), 2008-2013 21
Figure 2: Pharmaceutical Market, Australia, Revenue* Forecast ($bn), 2014-2020 22
Figure 3: Pharmaceutical Market, Australia, Exports and Imports ($bn), 2008-2013 23
Figure 4: Pharmaceutical Market, Australia, Distribution Channels, 2013 24
Figure 5: Pharmaceutical Market, Australia, Over-the-Counter Drugs Market ($bn), 2008-2013 28
Figure 6: Pharmaceutical Market, Australia, Top Five Therapeutic Areas, Pharmaceutical Expenditure ($bn), 2013 29
Figure 7: Pharmaceutical Market, Australia, Major Suppliers to PBS, Revenue ($m), 2013 32
Figure 8: Medical Device Market, Australia, Revenue ($bn), 2008-2013 71
Figure 9: Medical Device Market, Australia, Revenue Forecast ($bn), 2014-2020 72
Figure 10: Medical Device Market, Australia, Revenue by Segment ($m), 2013 73
Figure 11: Medical Device Market, Australia, IVD Market, Revenue ($m), 2008-2013 74
Figure 12: Medical Device Market, Australia, IVD Devices Market, Sales Trends for Major Players, 2008-2012 75
Figure 13: Medical Device Market, Australia, Orthopedics Devices Market, Revenue ($m), 2008-2013 77
Figure 14: Medical Device Market, Australia, Orthopedics Devices Market, Sales Trends for Major Players, 2008-2012 78
Figure 15: Medical Device Market, Australia, Ophthalmic Devices Market, Revenue ($m), 2008-2013 79
Figure 16: Medical Device Market, Australia, Ophthalmic Devices Market, Sales Trends for Major Players, 2008-2012 80
Figure 17: Medical Device Market, Australia, Cardiovascular Devices Market, Revenue ($m), 2008-2013 82
Figure 18: Medical Device Market, Australia, Cardiovascular Devices Market, Sales Trends for Major Players, 2008-2012 83
Figure 19: Medical Device Market, Australia, Diagnostic Imaging Market, Revenue ($m), 2008-2013 85
Figure 20: Medical Device Market, Australia, Diagnostic Market, Revenue ($bn), 2008-2013 87
Figure 21: Medical Device Market, Australia, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 88
Figure 22: Medical Device Market, Australia, Major Medical Device Companies' Revenue ($m), 2012 89
Figure 23: Healthcare Market, Australia, Drivers and Barriers, 2014 127
Figure 24: Healthcare System, Australia, Pharmaceuticals and Devices Reimbursement Process, 2014 131
Figure 25: Market Access, Australia, Private Insurance Coverage (million), 2008-2013 138
Figure 26: Healthcare Spending, Australia, Out-of-Pocket Expenditure (%), 2008-2013 139
Figure 27: Market Access, Australia, Healthcare Services, Average Price Change (%), 2008-2013 140
Figure 28: Market Access, Australia, Therapeutic Goods Administration Structure, 2014 144
Figure 29: Market Access, Australia, Registration Process Regulatory Phases, 2013 148
Figure 30: Market Access, Australia, Class I Non-sterile and Non-measuring Device Supply Process, 2013 151
Figure 31: Market Access, Australia, Supply Process for Medical Device Manufactured in Australia, 2013 152
Figure 32: Market Access, Australia, Supply Process for Medical Device Manufactured Overseas, 2013 153
Figure 33: Market Access, Australia, Supply Process for Medical Device Containing Medicine or Materials of Animal, Microbial Recombinant or Human Origin, 2013 154
Figure 34: Economic Indicators, Australia, Gross Domestic Product per Capita ($), 2008-2013 174
Figure 35: Economic Indicators, Australia, Gross Domestic Product per Capita Forecast ($), 2014-2020 175
Figure 36: Economic Indicators, Australia, Gross Domestic Product Annual Growth (%), 2008-2013 176
Figure 37: Economic Indicators, Australia, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 177
Figure 38: Economic Indicators, Australia, Gross National Income per Capita ($), 2008-2013 178
Figure 39: Economic Indicators, Australia, Average Consumer Price Index, 2008-2013 179
Figure 40: Economic Indicators, Australia, Average Consumer Price Index, Forecast, 2014-2020 180
Figure 41: Economic Indicators, Australia, Average Consumer Price, Annual Change (%), 2008-2013 181
Figure 42: Economic Indicators, Australia, Currency Exchange Rate (AUD/$), 2008-2013 183
Figure 43: Economic Indicators, Australia, Foreign Direct Investment ($bn), 2008-2013 184
Figure 44: Economic Indicators, Australia, Foreign Exchange Reserves ($bn), 2008-2013 185
Figure 45: Economic Indicators, Australia, Imports of Goods and Services ($bn), 2008-2013 186
Figure 46: Economic Indicators, Australia, Exports of Goods and Services ($bn), 2008-2013 188
Figure 47: Economic Indicators, Australia, General Government Structural Balance ($bn), 2008-2013 189
Figure 48: Economic Indicators, Australia, General Government Net Debt ($bn), 2008-2013 190
Figure 49: Economic Indicators, Australia, Major Industries, Gross Value Added (%), 2012-2013 191
Figure 50: Demographics, Australia, Population (million), 2008-2013 193
Figure 51: Demographics, Australia, Population Forecast (million), 2014-2020 194
Figure 52: Demographics, Australia, Population, Urban and Rural Population Share (%), 2008-2013 195
Figure 53: Demographics, Australia, Population, Urban and Rural Population Share Forecast (%), 2014-2020 196
Figure 54: Demographics, Australia, Population Distribution by Age Group (%), 2008-2013 198
Figure 55: Demographics, Australia, Population Distribution by Age Group Forecast (%), 2014-2020 199
Figure 56: Demographics, Australia, Births (per 1,000 Population), 2008-2013 200
Figure 57: Demographics, Australia, Mortality (per 1,000 Population), 2008-2013 201
Figure 58: Demographics, Australia, Major Causes of Mortality, 2012 202
Figure 59: Demographics, Australia, Children ?5 Years, Mortality Rate (per 1,000 Live Births), 2008-2013 204
Figure 60: Demographics, Australia, Immunization Rate (%), 2008-2013 205
Figure 61: Demographics, Australia, Major Causes of Male Mortality (‘000), 2012 206
Figure 62: Demographics, Australia, Major Causes of Female Mortality (‘000), 2012 207
Figure 63: Demographics, Australia, Gender Ratio (M/F), 2008-2013 209
Figure 64: Demographics, Australia, Life Expectancy at Birth (Years), 2008-2013 210
Figure 65: Demographics, Australia, Student Enrollment by Level of Education (% of Gross), 2011 213
Figure 66: Demographics, Australia, Overseas Student (%), 2008-2013 214
Figure 67: Demographics, Australia, Unemployment Rate (%), 2008-2013 216
Figure 68: Demographics, Australia, Major Causes of Hospitalization, 2012-2013 217
Figure 69: Demographics, Australia, Major Diseases, DALYs (per 100,000 Population), 2004 219
Figure 70: Healthcare Infrastructure, Australia, Hospitals, 2008-2013 220
Figure 71: Healthcare Infrastructure, Australia, Public and Private Hospitals, 2008-2013 221
Figure 72: Healthcare Infrastructure, Australia, Public Acute Care Hospitals, 2008-2013 222
Figure 73: Healthcare Infrastructure, Australia, Public Psychiatric Hospitals, 2008-2013 223
Figure 74: Healthcare Infrastructure, Australia, Private Free-standing Day Hospitals, 2008-2013 224
Figure 75: Healthcare Infrastructure, Australia, Other Private Hospitals, 2008-2013 225
Figure 76: Healthcare Infrastructure, Australia, Diagnostic Equipment (per Million Population), 2008-2013 226
Figure 77: Healthcare Infrastructure, Australia, Total Hospital Beds (per 1,000 Population), 2008-2013 227
Figure 78: Healthcare Infrastructure, Australia, Public Hospital Beds (per 1,000 Population), 2008-2013 228
Figure 79: Healthcare Infrastructure, Australia, Private Hospital Beds (per 1,000 Population), 2008-2013 229
Figure 80: Healthcare Infrastructure, Australia, Doctors (per 100,000 Population), 2008-2013 230
Figure 81: Healthcare Infrastructure, Australia, PM10 (µg/m3), 2008-2013 232
Figure 82: Healthcare Infrastructure, Australia, CO2 Emissions (Million Metric Tons), 2008-2013 234
Figure 83: Healthcare Infrastructure, Australia, Nurses (per 1,000 Population), 2008-2013 235
Figure 84: Healthcare Infrastructure, Australia, Pharmacists (per 1,000 Population), 2008-2013 236
Figure 85: Healthcare Infrastructure, Australia, Dentists (per 1,000 Population), 2008-2013 237
Figure 86: Healthcare Expenditure, Australia, Healthcare Expenditure (% of GDP), 2008-2013 239
Figure 87: Healthcare Expenditure, Australia, Healthcare Expenditure, Major Components (%), 2012 240
Figure 88: Healthcare Expenditure, Australia, Healthcare Expenditure, Public-Private Share (%), 2008-2013 241
Figure 89: Healthcare Expenditure, Australia, Research and Development Expenditure in Medical and Health Sciences ($m), 2008-2013 242
Figure 90: Healthcare Market, Australia, Opportunities and Challenges, 2014 246

Published By: GlobalData
Product Code: GlobalData30458


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: